
Prophylactic and Anaphylactic Approaches Towards COVID 19 in India – An Overview
Author(s) -
Rajendran Vinoth,
V. Manikandan,
C. Tamilselvan,
Shivan Sivakumar,
Natalie Jayaram
Publication year - 2021
Publication title -
international journal of pharmaceutical sciences and medicine
Language(s) - English
Resource type - Journals
ISSN - 2519-9889
DOI - 10.47760/ijpsm.2021.v06i10.002
Subject(s) - covid-19 , middle east respiratory syndrome , middle east respiratory syndrome coronavirus , medicine , intensive care medicine , coronavirus infections , disease , virology , infectious disease (medical specialty) , outbreak
Coronaviruses can cause a variety of disorders in the respiratory and gastrointestinal systems. Anything from a simple cold to something more serious like the Middle East Respiratory Syndrome (MERS-CoV) or SARS can induce breathing issues (SARS-CoV). The inquiry focused on COVID 19 symptoms, diagnosis, and treatment. Medication and immunizations were used to treat nCOV. Vaccines are currently being used all around the world to prevent disease. The approved vaccine candidates in India through September 2021 are listed on this work. These data are critical for future COVID 19 treatment reference and will be quite useful.